3テスラMRIによる中脳黒質neuromelanin-related contrastの描出:正常およびパーキンソン病における比較

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Rinshō shinkeigaku Clinical neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.5692/CLINICALNEUROL.51.14
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging

  2010cited by this paper
• Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Detection of presymptomatic Parkinson's disease: Combining smell tests, transcranial sonography, and SPECT

  2004cited by this paper
• Structural changes in the midbrain with aging and Parkinson's disease: an MRI study.

  2004cited by this paper
• The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

  2002cited by this paper
• Age-related structural changes in the human midbrain: an MR image study.

  2001cited by this paper
• Parkinson病の重症度を測る日本語版unified Parkinson’s disease rating scale(UPDRS)の信頼性評価

  2000cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

  1991cited by this paper
• Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells.

  1974cited by this paper

• Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease

  2020cites this paper
• Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson’s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis

  2020cites this paper
• Olivary hypertrophy improved by steroid treatment: Two case reports with unique presentations.

  2019cites this paper
• Low Pulvinar Intensity in Susceptibility-Weighted Imaging May Suggest Cognitive Worsening After Deep Brain Stimulation Therapy in Patients With Parkinson's Disease

  2019cites this paper
• Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

  2018cites this paper
• A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.

  2016cites this paper
• Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia

  2014cites this paper
• Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy

  2013cites this paper